throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`DR. REDDY’S LABORATORIES S.A. and
`DR. REDDY’S LABORATORIES, INC.
`Petitioners,
`
`v.
`
`MONOSOL RX, LLC
`Patent Owner
`
`
`
`
`
`
`
`Case No. IPR2017-01582
`Patent No. 8,603,514
`
`
`
`
`
`
`
`
`PETITIONERS’ REPLY IN SUPPORT OF THE MOTION FOR JOINDER
`WITH IPR2017-00200
`
`
`
`
`
`
`
`
`
`

`

`I.
`
`INTRODUCTION
`
`Monosol RX, LLC (“Patent Owner”) opposed Dr. Reddy’s Laboratories,
`
`S.A. and Dr. Reddy’s Laboratories, Inc.’s (collectively, “DRL” or “Petitioners”)
`
`Motion for Joinder of its proceeding, IPR2017-01582, with Mylan Technologies
`
`Inc.’s (“Mylan”) IPR2017-00200 (“the ’200 IPR”) because, at the time that DRL
`
`filed its Motion for Joinder, DRL and Mylan had not yet finalized an agreement to
`
`cooperate in a joint IPR proceeding. At the same time, Monosol did not oppose a
`
`nearly identical motion for joinder by Par Pharmaceutical, Inc. (“Par”) based on a
`
`representation by Par that it had an agreement to cooperate with Mylan. As
`
`foreshadowed in DRL’s opening brief, Mylan and DRL have now finalized their
`
`agreement to cooperate in a joint IPR proceeding, and Mylan does not oppose
`
`DRL’s motion for joinder. DRL’s agreement with Mylan and Par’s agreement
`
`with Mylan (as described by Patent Owner) each provides the same conditions for
`
`joinder, with DRL and Par each adopting the familiar “understudy” role of a joined
`
`petitioner.
`
`
`
`DRL’s agreement with Mylan addresses every valid concern raised by
`
`Patent Owner in its Opposition to Petitioners’ Motion for Joinder, and effectively
`
`moots the opposition. The Board should therefore grant Petitioners’ motion.
`
`1
`
`
`

`

`II. ARGUMENT
`
`Patent Owner’s principal argument in opposition to Petitioners’ Motion for
`
`Joinder was that, since Mylan and DRL had not agreed on the conditions under
`
`which a joined IPR would proceed, joinder of DRL to the ’200 IPR would delay
`
`the “just, speedy, and inexpensive” resolution of that proceeding. (Opposition, at
`
`12.) DRL’s agreement with Mylan ensures that joining DRL would not interfere
`
`with the schedule of the ’200 IPR and would not delay resolution.
`
`Under Mylan and DRL’s agreement, DRL will take the familiar
`
`“understudy” role of a petitioner joined to an instituted IPR. Specifically, DRL has
`
`agreed that, so long as Mylan remains a party to the IPR: (1) DRL will rely on the
`
`expert declaration of Mylan’s expert in the ’200 IPR; (2) DRL will not receive any
`
`separate cross examination or redirect time during witness depositions, and cross
`
`examinations will occur within the timeframe normally allotted by the Board’s
`
`rules to one party; and (3) DRL will incorporate its filings with those of Mylan in
`
`consolidated filings, subject to the Board’s rules for one party on page limits. DRL
`
`further agrees to adopt a silent role in all communications with the Board and at the
`
`oral hearing for the joined proceeding.
`
`DRL’s Petition presents the same ground of unpatentability that was
`
`instituted in the ’200 IPR, and relies on the same documentary evidence, with the
`
`exception of the expert declaration. Along with its Petition, DRL relied on the
`
`2
`
`
`

`

`declaration of its own expert who offered testimony that is nearly identical to the
`
`testimony offered by Mylan’s expert declarant in the ’200 IPR. DRL understands
`
`that, upon joinder with the ’200 IPR, the instant IPR proceeding will be terminated
`
`and DRL’s expert declaration will not be of record in the joined proceeding. DRL
`
`therefore has received Mylan’s consent to retain Mylan’s declarant, Dr. Buckton,
`
`to work with DRL for purposes of the joined IPR. Since DRL will not have any
`
`expert that is not also an expert for Mylan, joining DRL will not necessitate any
`
`further depositions and will therefore not affect the schedule for the ’200 IPR.
`
`Par has also filed a petition challenging the patentability of the ’514 patent,
`
`along with a motion for joinder with the ’200 IPR. Patent Owner has stated that it
`
`does not oppose Par’s motion for joinder because Par agreed with Mylan to play an
`
`understudy role in the joined IPR, and its participation would therefore not affect
`
`the schedule of the ’200 IPR. (Opposition, at 9-10 and note 4.) Because DRL has
`
`agreed to play an understudy role in the joined proceeding, identical to the
`
`understudy role that Par has agreed to play in the joined proceeding (compare the
`
`terms listed above with the terms listed in Par’s Motion for Joinder, IPR2017-
`
`01557, Paper 4, at 5-6), Patent Owner’s concerns regarding joinder of DRL are
`
`addressed.
`
`For all of the reasons stated in Petitioner’s Motion for Joinder, joining DRL
`
`to the ’200 IPR would further the Board’s “policy preference for joining a party
`
`3
`
`
`

`

`that does not present new issues that might complicate or delay an existing
`
`proceeding.” Enzymotec Ltd. v. Neptune Techs & Bioresources, Inc., IPR2014-
`
`00556, Paper 19 at 6 (P.T.A.B. Jul. 9, 2014). The decisions that Patent Owner
`
`cites in its Opposition, having entirely different factual patterns than those present
`
`here, do not instruct otherwise. In Samsung Elects. Co. v. Affinity Labs of Texas,
`
`LLC, IPR2015-00820, Paper 12 (P.T.A.B. May 15, 2015), the Board denied joinder
`
`for Samsung’s fourth petition for IPR of the same patent, after having granted each
`
`of the first three petitions. In both LG Elects. Inc. v. ATI Techs. ULD, IPR2015-
`
`01620, Paper 10 (P.T.A.B. Feb. 2, 2016) and Reloaded Games, Inc. v. Parallel
`
`Networks, LLC, IPR2014-00950, Paper 12 (P.T.A.B. Oct. 22, 2014), the Board
`
`denied petitioner’s motion to join an IPR in which it was itself the petitioner. The
`
`second petition relied on different grounds and concerned different claims than
`
`were involved in the already-instituted IPR. Thus, joinder would have added new
`
`issues into the instituted IPR. And, in Ubisoft, Inc. v. Uniloc USA, Inc., IPR2016-
`
`00414, Paper 16 (P.T.A.B. Jun. 2, 2016), the Board denied joinder to an IPR that
`
`had already been terminated (and it was petitioner’s third petition; the first IPR had
`
`reached a final written decision and the first CBM had been denied institution).
`
`In this case, DRL’s petition presents only challenges identical to those that
`
`are already instituted by the Board. Joinder is therefore appropriate because it will
`
`4
`
`
`

`

`promote efficient and consistent resolution of the unpatentability grounds at issue
`
`and will not prejudice any of the parties to the ’200 IPR.
`
`III. CONCLUSION
`
`DRL’s agreement with Mylan addresses all of Patent Owner’s concerns
`
`regarding the schedule for the ’200 IPR, and DRL’s joinder will not, in any way,
`
`affect the just, speedy, and inexpensive resolution of the proceeding. Joinder is
`
`therefore appropriate under 37 C.F.R. § 42.1(b) and under the Board’s precedent.
`
`Petitioners respectfully request that the Board grant their Motion for Joinder with
`
`the ’200 IPR.
`
`
`
`
`
`
`
`
`
`
`
`Dated: July 26, 2017
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`5
`
`
`Respectfully submitted,
`
`
`
`/Ira J. Levy/
`Ira J. Levy (Reg. No. 35,587)
`GOODWIN PROCTER LLP
`The New York Times Building
`620 Eighth Avenue
`New York, NY 10018
`Tel.: 212-459-7456
`Fax: 646-558-4143
`ILevy@goodwinlaw.com
`
`Counsel for Petitioners Dr. Reddy’s
`Laboratories S.A. and Dr. Reddy’s
`Laboratories, Inc.
`
`

`

`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that this “PETITIONERS’ REPLY IN
`
`
`
`SUPPORT OF THE MOTION FOR JOINDER WITH IPR2017-00200” was
`
`served on this 26th day of July 2017 on Patent Owner by email to Patent Owner’s
`
`counsel of record at the following addresses provided in Patent Owner’s
`
`Mandatory Notices:
`
`hfox@steptoe.com
`514MIPR@steptoe.com
`
`
`
`Courtesy copies of the foregoing were also served on counsel for Mylan in
`
`the ’200 IPR by email at the following addresses provided in Mylan’s Mandatory
`
`Notices in that proceeding:
`
`
`
`
`
`
`
`
`
`
`
`
`/Sarah Fink/
`Sarah Fink (Reg. No. 64,886)
`
`sparmelee@wsgr.com
`mrosato@wsgr.com
`jmills@wsgr.com
`
`
`Dated: July 26, 2017
`
`
`
`
`
`
`
`
`
`
`
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket